Home Genentech

Genentech

acquired
IPO Delisting
Pharmaceutical R&D Manufacturer

Basic Information

Genentech is a biotechnology company founded in 1976 by Robert Swanson and Herbert Boyer, dedicated to researching and developing medicines to treat patients with serious or life-threatening diseases. Our transformative discoveries include the first targeted antibody for cancer and the first treatment for primary progressive multiple sclerosis.
Genentech, Inc.
California,United States of America
more than 500 people
January 01, 1976
--